Increased neonatal thyrotropin in Down syndrome

Area of Science:

• Endocrinology
• Genetics
• Pediatrics

Background:

• Down syndrome (DS) is a genetic disorder frequently linked to endocrine abnormalities, especially thyroid dysfunction.
• Thyroid dysfunction in DS can manifest as hypothyroidism, impacting development and health.
• Neonatal screening is crucial for early detection of potential health issues in infants with DS.

Purpose of the Study:

• To evaluate neonatal screening thyrotropin (TSH) levels in infants with Down syndrome (DS).
• To determine the association between neonatal TSH levels and the development of hypothyroidism in childhood among DS individuals.
• To identify potential predictors of thyroid dysfunction in DS patients.

Main Methods:

• Retrospective analysis of neonatal screening TSH levels in 73 children with DS (born 1986-1996) compared to controls.
• Longitudinal follow-up of thyroid function in DS children until age 10.
• Descriptive study design to assess TSH levels and thyroid outcomes.

Main Results:

• Infants with DS showed significantly higher mean TSH levels and TSH standard deviation scores (SDS) compared to controls.
• Elevated TSH levels were more pronounced in male infants with DS.
• Neonatal TSH levels did not reliably predict the development of thyroid dysfunction during childhood.

Conclusions:

• Neonatal screening reveals elevated TSH in infants with DS, particularly males, indicating subclinical hypothyroidism early in life.
• While indicative of early thyroid changes, neonatal TSH levels are not predictive of manifest thyroid disease later in childhood for DS individuals.